LOR Antikörper (N-Term)

Produktnummer ABIN629750

Der Kaninchen Polyklonal anti-LOR Antikörper wird verwendet zum Nachweis von LOR. Er wurde validiert für WB und IHC.

Kurzübersicht für LOR Antikörper (N-Term) (ABIN629750)

Target: LOR (Loricrin (LOR))

Reaktivität: Bitte anfragen

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LOR Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Produktdetails anti-LOR Antikörper

Bindungsspezifität: N-Term

Spezifität: Loricrin antibody was raised against the N terminal of LOR

Aufreinigung: Purified

Immunogen: Loricrin antibody was raised using the N terminal of LOR corresponding to a region with amino acids GYSGGGCGGGSSGGGGGGGIGGCGGGSGGSVKYSGGGGSSGGGSGCFSSG

Anwendungsinformationen

Applikationshinweise: WB: 5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

Loricrin Blocking Peptide, (ABIN939071), is also available for use as a blocking control in assays to test for specificity of this Loricrin antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LOR antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu LOR

Target: LOR (Loricrin (LOR))

Andere Bezeichnung: Loricrin

Substanzklasse: Chemical

Hintergrund: LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.

Molekulargewicht: 35 kDa (MW of target protein)